Literature DB >> 10753971

Acetylation of novel sites in the nucleosomal binding domain of chromosomal protein HMG-14 by p300 alters its interaction with nucleosomes.

M Bergel1, J E Herrera, B J Thatcher, M Prymakowska-Bosak, A Vassilev, Y Nakatani, B Martin, M Bustin.   

Abstract

The reversible acetylation of histones is associated with structural alterations in the chromatin fiber that affect various DNA-related activities. Here we show that the histone acetyltransferase p300 specifically acetylates HMG-14, a nonhistone structural protein that binds to nucleosomes and reduces the compactness of the chromatin fiber. We identify 7 major acetylation sites, 6 of which are novel and have not been known to be acetylated in either HMG-14 or the closely related HMG-17 protein. All the acetylation sites involve evolutionarily conserved residues: 3 within the HMG-14/-17 nucleosomal binding domain and 4 in or near the bipartite nuclear localization domains of the proteins. In tissue culture cells the acetylation pattern is indicative of a selective process in which a subfraction of HMG-14 is preferentially acetylated. We find that the nucleosomal binding domain is a major target for acetylation in vivo and that the specific acetylation of HMG-14 by p300 weakens its interaction with nucleosome cores. Our results suggest that p300 modulates the interaction of HMG-14 with nucleosomes. Thus, p300 may affect chromatin-related activities not only by modifying histones or transcription factors but also by targeting structural nonhistone proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753971     DOI: 10.1074/jbc.275.15.11514

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia.

Authors:  M E Bianchi; M Beltrame
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

2.  Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.

Authors:  M Prymakowska-Bosak; T Misteli; J E Herrera; H Shirakawa; Y Birger; S Garfield; M Bustin
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.

Authors:  Terry R Medler; Justin M Craig; Alyson A Fiorillo; Yvonne B Feeney; J Chuck Harrell; Charles V Clevenger
Journal:  Mol Cancer Res       Date:  2016-06-29       Impact factor: 5.852

Review 4.  High mobility group proteins and their post-translational modifications.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2008-05-10

5.  Evolution of high mobility group nucleosome-binding proteins and its implications for vertebrate chromatin specialization.

Authors:  Rodrigo González-Romero; José M Eirín-López; Juan Ausió
Journal:  Mol Biol Evol       Date:  2014-10-03       Impact factor: 16.240

Review 6.  Expression of the stress-associated protein p8 is a requisite for tumor development.

Authors:  Juan L Iovanna
Journal:  Int J Gastrointest Cancer       Date:  2002

Review 7.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

Review 8.  HMGNs, DNA repair and cancer.

Authors:  Gabi Gerlitz
Journal:  Biochim Biophys Acta       Date:  2009-12-08

9.  p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.

Authors:  Sumit Isharwal; Michael C Miller; Cameron Marlow; Danil V Makarov; Alan W Partin; Robert W Veltri
Journal:  Prostate       Date:  2008-07-01       Impact factor: 4.104

10.  The SIRT2 deacetylase regulates autoacetylation of p300.

Authors:  Joshua C Black; Amber Mosley; Tasuku Kitada; Michael Washburn; Michael Carey
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.